澳大利亚与加拿大5-11岁儿童未接种疫苗的家长报告动机比较:iCARE研究结果
基于iCARE研究,2022年5月20日至9月12日在加拿大和澳大利亚收集两个横断面代表性样本,比较5-11岁儿童家长报告的COVID-19疫苗接种率变化及接种与未接种动机。儿童接种率在研究期间未上升(T1=87%,T2=86%;OR=0.83;95%CI=0.45-1.54),加拿大(60.8%)低于澳大利亚(71.6%)(OR=0.56;95%CI=0.33-0.96)。两国未接种家长的社会经济特征相似,疫苗短期或长期副作用信息均为重要动机,但疫苗有效性在加拿大更重要,对研发公司的信任和儿童医生的推荐在澳大利亚更重要。
要点
- 5-11岁儿童家长报告接种率研究期间未上升(T1=87%,T2=86%;OR=0.83;95%CI=0.45-1.54)。
- 加拿大儿童接种率(60.8%)低于澳大利亚(71.6%)(OR=0.56;95%CI=0.33-0.96)。
- 两国未接种家长均重视疫苗短期或长期副作用信息;疫苗有效性在加拿大更重要,对研发公司信任和医生推荐在澳大利亚更重要。
核心结论
- 5-11岁儿童家长报告接种率在疫苗推广早期即进入平台期,未接种儿童家长的主要动机在两国间存在差异,但疫苗安全性和有效性信息是两国共同关注点。
研究设计与样本
- 作为iCARE研究的一部分,于2022年5月20日至9月12日(即5-11岁儿童COVID-19疫苗推广后5个月和9个月)通过在线面板在加拿大和澳大利亚收集两个横断面代表性样本。
- 家长/监护人报告其子女的疫苗接种状态及接种与未接种动机。
- 采用一般线性模型估计两国间疫苗接种率及动机随时间的变化差异。
主要发现
- 家长报告的5-11岁儿童疫苗接种率在研究期间未上升(T1=87%,T2=86%;OR=0.83;95%CI=0.45-1.54)。
- 加拿大儿童接种率(60.8%)低于澳大利亚(71.6%)(OR=0.56;95%CI=0.33-0.96)。
- 两国未接种儿童家长的社会经济特征相似,疫苗短期或长期副作用信息均为重要动机。
- 疫苗有效性在加拿大更重要,对研发公司的信任和儿童医生的推荐在澳大利亚更重要。
关键数值与推荐
- 家长报告5-11岁儿童疫苗接种率:T1=87%,T2=86%(OR=0.83;95%CI=0.45-1.54)。
- 加拿大儿童接种率60.8% vs 澳大利亚71.6%(OR=0.56;95%CI=0.33-0.96)。
临床怎么用
- 研究结果可能为澳大利亚和加拿大未来量身定制的疫苗沟通努力和大流行规划提供信息,以优化小学儿童的疫苗接种率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite COVID-19 infection being less severe in children compared to adults, vaccination for children from the age of 6 months onwards is recommended in many countries to reduce symptom severity and prevent severe disease. However, vaccination against COVID-19 for children remains controversial and uptake has been low. AIMS: To assess and compare the rate of change of parent-reported COVID-19 vaccine uptake in children aged 5 to 11 years and motivators of vaccine acceptance and non-vaccination among parents/guardians in Canada and Australia. METHODS: As part of the iCARE study, two cross-sectional representative samples in Canada and Australia were collected between May 20 and September 12, 2022 (i.e., 5 and 9 months after the COVID-19 vaccine rollout for children 5-11 years) using online panels. Parents/guardians reported the vaccine status of their children and motivators for vaccine acceptance and non-vaccination. General linear models were used to estimate differences between countries in terms of vaccine uptake and motivators across time. RESULTS: Parent-reported vaccine uptake for children 5-11 years didn't increase over the study period (T1 = 87 %,T2 = 86 %; OR = 0.83; 95 %CI = 0.45-1.54) and was overall lower in Canada (60.8 %) compared to Australia (71.6 %)(OR = 0.56; 95 %CI = 0.33-0.96). In both countries the socioeconomic characteristics of parents who didn't vaccinate their children were similar and having information on either the short- or long-term side effects of the vaccine were important motivators. However, vaccine effectiveness was more important in Canada and trust in the company that developed the vaccine and a recommendation from the child's doctor were more important motivators in Australia. CONCLUSION: Parent-reported vaccine uptake for children 5-11 years plateaued early in the vaccine rollout. The main motivators for parents of unvaccinated children varied between the two countries but information on vaccine safety and effectiveness were common to both countries. Findings may inform future tailored vaccine communication efforts and pandemic planning in Australia and Canada to optimize vaccine uptake for primary school children.
引用
- Deslauriers F, Hoq M, Kaufman J, et al. Comparison of parent-reported motivators of non-vaccination for children 5-11 years old in Australia and Canada: Results of the iCARE study. Vaccine. 2024. PMID: 38880694. doi:10.1016/j.vaccine.2024.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。